As of 2024-12-11, the Intrinsic Value of Black Diamond Therapeutics Inc (BDTX) is
-6.46 USD. This BDTX valuation is based on the model Peter Lynch Fair Value.
With the current market price of 2.44 USD, the upside of Black Diamond Therapeutics Inc is
-364.70%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
-6.46 USD
Intrinsic Value
BDTX Intrinsic Value - Valuation Summary
|
Range |
Selected |
Upside |
| a |
| Fair Value |
-6.46 - -6.46 |
-6.46 |
-364.70% |
| P/E |
(14.70) - (25.29) |
(24.09) |
-1087.3% |
| DDM - Stable |
(9.29) - (30.92) |
(20.10) |
-923.8% |
| DDM - Multi |
(3.39) - (8.94) |
(4.94) |
-302.3% |
BDTX Intrinsic Value - Key Valuation Metrics
| Market Cap (mil) |
138.08 |
| Beta |
2.26 |
| Outstanding shares (mil) |
56.59 |
| Enterprise Value (mil) |
114.65 |
| Market risk premium |
4.60% |
| Cost of Equity |
10.75% |
| Cost of Debt |
5.00% |
| WACC |
7.21% |